{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:08:24Z","timestamp":1761919704299},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T00:00:00Z","timestamp":1369008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T00:00:00Z","timestamp":1369008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,4,24]]},"DOI":"10.1038\/onc.2013.177","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T10:51:01Z","timestamp":1369047061000},"page":"2191-2203","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma"],"prefix":"10.1038","volume":"33","author":[{"given":"K","family":"Teshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,20]]},"reference":[{"key":"BFonc2013177_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","volume":"142","author":"P Jares","year":"2008","unstructured":"Jares P, Campo E . Advances in the understanding of mantle cell lymphoma. Br J Haematol 2008; 142: 149\u2013165.","journal-title":"Br J Haematol"},{"key":"BFonc2013177_CR2","first-page":"158","volume-title":"World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Seto M, Muller-Hermelink HK . Mantle cell lymphoma. In: Swerdloe AH, Campo E, Harris NL, Jaffe ES, Stein H, Thiele J, Vardiman JW eds.) World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press, Washington Lyon, 2008. 158\u2013178."},{"key":"BFonc2013177_CR3","first-page":"2409","volume":"61","author":"S Be\u00e0","year":"2001","unstructured":"Be\u00e0 S, Tort F, Pinyol M, Puig X, Hern\u00e1ndez L, Hern\u00e1ndez S et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001; 61: 2409\u20132412.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24: 1348\u20131358.","journal-title":"Oncogene"},{"key":"BFonc2013177_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","volume":"109","author":"C Mestre-Escorihuela","year":"2007","unstructured":"Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007; 109: 271\u2013280.","journal-title":"Blood"},{"key":"BFonc2013177_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","volume":"113","author":"S Be\u00e0","year":"2009","unstructured":"Be\u00e0 S, Salaverria I, Armengol L, Pinyol M, Fern\u00e1ndez V, Hartmann EM et al. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. Blood 2009; 113: 3059\u20133069.","journal-title":"Blood"},{"key":"BFonc2013177_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/353353a0","volume":"353","author":"M van Lohuizen","year":"1991","unstructured":"van Lohuizen M, Frasch M, Wientjens E, Berns A . Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2. Nature 1991; 353: 353\u2013355.","journal-title":"Nature"},{"key":"BFonc2013177_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature02385","volume":"428","author":"C Leung","year":"2004","unstructured":"Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004; 428: 337\u2013341.","journal-title":"Nature"},{"key":"BFonc2013177_CR9","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1038\/onc.2009.165","volume":"28","author":"MJ Hoenerhoff","year":"2009","unstructured":"Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP et al. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene 2009; 28: 3022\u20133032.","journal-title":"Oncogene"},{"key":"BFonc2013177_CR10","doi-asserted-by":"publisher","first-page":"e14648","DOI":"10.1371\/journal.pone.0014648","volume":"6","author":"Z Wu","year":"2011","unstructured":"Wu Z, Min L, Chen D, Hao D, Duan Y, Qiu G et al. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PLoS One 2011; 6: e14648.","journal-title":"PLoS One"},{"key":"BFonc2013177_CR11","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1158\/1078-0432.CCR-11-0071","volume":"17","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao H et al. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res 2011; 17: 7105\u20137015.","journal-title":"Clin Cancer Res"},{"key":"BFonc2013177_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/16476","volume":"397","author":"JJ Jacobs","year":"1999","unstructured":"Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M . The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397: 164\u2013168.","journal-title":"Nature"},{"key":"BFonc2013177_CR13","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1101\/gad.13.20.2678","volume":"13","author":"JJ Jacobs","year":"1999","unstructured":"Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M . Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a\/ARF. Genes Dev 1999; 13: 2678\u20132690.","journal-title":"Genes Dev"},{"key":"BFonc2013177_CR14","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1172\/JCI39374","volume":"119","author":"LB Song","year":"2009","unstructured":"Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009; 119: 3626\u20133636.","journal-title":"J Clin Invest"},{"key":"BFonc2013177_CR15","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1158\/0008-5472.CAN-09-4229","volume":"70","author":"Z Jagani","year":"2010","unstructured":"Jagani Z, Wiederschain D, Loo A, He D, Mosher R, Fordjour P et al. The polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells. Cancer Res 2010; 70: 5528\u20135538.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1349-7006.2011.01891.x","volume":"102","author":"M Kimura","year":"2011","unstructured":"Kimura M, Takenobu H, Akita N, Nakazawa A, Ochiai H, Shimozato O et al. Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells. Cancer Sci 2011; 102: 983\u2013990.","journal-title":"Cancer Sci"},{"key":"BFonc2013177_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard J, Sauvageau G . Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255\u2013260.","journal-title":"Nature"},{"key":"BFonc2013177_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nature02060","volume":"425","author":"AV Molofsky","year":"2003","unstructured":"Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ . Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425: 962\u2013967.","journal-title":"Nature"},{"key":"BFonc2013177_CR19","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","volume":"66","author":"S Liu","year":"2006","unstructured":"Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006; 66: 6063\u20136071.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR20","doi-asserted-by":"publisher","first-page":"11857","DOI":"10.1073\/pnas.0803574105","volume":"105","author":"JS Dovey","year":"2008","unstructured":"Dovey JS, Zacharek SJ, Kim CF, Lees JA . Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci USA 2008; 105: 11857\u201311862.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013177_CR21","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1158\/0008-5472.CAN-07-5882","volume":"68","author":"T Chiba","year":"2008","unstructured":"Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y et al. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 2008; 68: 7742\u20137749.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR22","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1182\/blood.V97.12.3882","volume":"97","author":"M Feuring-Buske","year":"2001","unstructured":"Feuring-Buske M, Hogge DE . Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38- progenitor cells from patients with acute myeloid leukemia. Blood 2001; 97: 3882\u20133889.","journal-title":"Blood"},{"key":"BFonc2013177_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm0901-1028","volume":"7","author":"S Zhou","year":"2001","unstructured":"Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ et al. The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028\u20131034.","journal-title":"Nat Med"},{"key":"BFonc2013177_CR24","first-page":"343","volume":"290","author":"MA Goodell","year":"2005","unstructured":"Goodell MA, Kinney-Freeman S, Camargo FD . Isolation and characterization of side population cells. Methods Mol Biol 2005; 290: 343\u2013352.","journal-title":"Methods Mol Biol"},{"key":"BFonc2013177_CR25","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","volume":"65","author":"L Patrawala","year":"2005","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG . Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2\u2212 cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207\u20136219.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1634\/stemcells.2005-0282","volume":"24","author":"N Haraguchi","year":"2006","unstructured":"Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006; 24: 506\u2013513.","journal-title":"Stem Cells"},{"key":"BFonc2013177_CR27","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R et al. Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 2006; 103: 11154\u201311159.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013177_CR28","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","volume":"67","author":"MM Ho","year":"2007","unstructured":"Ho MM, Ng AV, Lam S, Hung JY . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827\u20134833.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR29","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1210\/en.2006-1553","volume":"148","author":"N Mitsutake","year":"2007","unstructured":"Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007; 148: 1797\u20131803.","journal-title":"Endocrinology"},{"key":"BFonc2013177_CR30","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-06-4343","volume":"67","author":"J Wang","year":"2007","unstructured":"Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH . Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007; 67: 3716\u20133724.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR31","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1158\/0008-5472.CAN-07-0999","volume":"67","author":"C Wu","year":"2007","unstructured":"Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 2007; 67: 8216\u20138222.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL . Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105\u2013111.","journal-title":"Nature"},{"key":"BFonc2013177_CR33","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan CT, Guzman ML, Noble M . Cancer stem cells. N Engl J Med 2006; 355: 1253\u20131261.","journal-title":"N Engl J Med"},{"key":"BFonc2013177_CR34","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.1158\/0008-5472.CAN-08-2629","volume":"68","author":"J Godlewski","year":"2008","unstructured":"Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G et al. Targeting of the Bmi-1 oncogene\/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008; 68: 9125\u20139130.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR35","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","volume":"69","author":"R Bhattacharya","year":"2009","unstructured":"Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009; 69: 9090\u20139095.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","volume":"138","author":"Y Shimono","year":"2009","unstructured":"Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138: 592\u2013603.","journal-title":"Cell"},{"key":"BFonc2013177_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1476-4598-10-99","volume":"10","author":"P Dong","year":"2011","unstructured":"Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J et al. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 2011; 10: 99.","journal-title":"Mol Cancer"},{"key":"BFonc2013177_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/onc.2011.263","volume":"31","author":"L Sun","year":"2012","unstructured":"Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012; 31: 432\u2013445.","journal-title":"Oncogene"},{"key":"BFonc2013177_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.20072000","volume":"205","author":"M Yamashita","year":"2008","unstructured":"Yamashita M, Kuwahara M, Suzuki A, Hirahara K, Shinnaksu R, Hosokawa H et al. Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J Exp Med 2008; 205: 1109\u20131120.","journal-title":"J Exp Med"},{"key":"BFonc2013177_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","volume":"23","author":"OA O'Connor","year":"2005","unstructured":"O'Connor OA, Wright J, Moskowitz C, Muzzy J, MacGregor-Cortelli B, Stubblefield M et al. Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma. J Clin Oncol 2005; 23: 676\u2013684.","journal-title":"J Clin Oncol"},{"key":"BFonc2013177_CR41","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1200\/JCO.2006.07.9665","volume":"24","author":"RI Fisher","year":"2006","unstructured":"Fisher RI, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S et al. Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol 2006; 24: 4867\u20134874.","journal-title":"J Clin Oncol"},{"key":"BFonc2013177_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1101\/gad.415507","volume":"21","author":"AP Bracken","year":"2007","unstructured":"Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21: 525\u2013530.","journal-title":"Genes Dev"},{"key":"BFonc2013177_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ccr.2007.08.032","volume":"12","author":"SW Bruggeman","year":"2007","unstructured":"Bruggeman SW, Hulsman D, Tanger E, Buckle T, Biom M, Zevenhoven J et al. Bmi1 controls tumor development in an Ink4a\/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007; 12: 328\u2013341.","journal-title":"Cancer Cell"},{"key":"BFonc2013177_CR44","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1158\/0008-5472.CAN-07-6152","volume":"68","author":"D Douglas","year":"2008","unstructured":"Douglas D, Hsu JH, Hung L, Cooper A, Abdueva D, van Doorninck J et al. BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res 2008; 68: 6507\u20136515.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR45","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","volume":"19","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Seto M . A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 2005; 19: 2013\u20132016.","journal-title":"Leukemia"},{"key":"BFonc2013177_CR46","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2008-03-142182","volume":"112","author":"RW Chen","year":"2008","unstructured":"Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK et al. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 2008; 112: 822\u2013829.","journal-title":"Blood"},{"key":"BFonc2013177_CR47","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","volume":"115","author":"JJ Zhao","year":"2010","unstructured":"Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010; 115: 2630\u20132639.","journal-title":"Blood"},{"key":"BFonc2013177_CR48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1182\/blood-2008-07-163907","volume":"113","author":"M Inomata","year":"2009","unstructured":"Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K . MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009; 113: 396\u2013402.","journal-title":"Blood"},{"key":"BFonc2013177_CR49","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944\u201313949.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013177_CR50","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/1541-7786.MCR-10-0344","volume":"9","author":"M Ofir","year":"2011","unstructured":"Ofir M, Hacohen D, Ginsberg D . miR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 2011; 9: 440\u2013447.","journal-title":"Mol Cancer Res"},{"key":"BFonc2013177_CR51","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/bcr3187","volume":"14","author":"MA Rivas","year":"2012","unstructured":"Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang THM, Elizalde PV . Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 2012; 14: R77.","journal-title":"Breast Cancer Res"},{"key":"BFonc2013177_CR52","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1158\/0008-5472.CAN-12-1400","volume":"72","author":"LM Pouliot","year":"2012","unstructured":"Pouliot LM, Chen YC, Bai J, Guha R, Martin SE, Gottesman MM et al. Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer Res 2012; 72: 5945\u20135955.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR53","doi-asserted-by":"publisher","first-page":"e44546","DOI":"10.1371\/journal.pone.0044546","volume":"7","author":"KT Kim","year":"2012","unstructured":"Kim KT, Carroll AP, Mashkani B, Cairns MJ, Small D, Scott RJ . MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and Interacts with Pim-1. PLoS One 2012; 7: e44546.","journal-title":"PLoS One"},{"key":"BFonc2013177_CR54","doi-asserted-by":"publisher","first-page":"e30772","DOI":"10.1371\/journal.pone.0030772","volume":"7","author":"R Zhou","year":"2012","unstructured":"Zhou R, Li X, Hu G, Gong AY, Drescher KM, Chen XM . MiR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PLoS One 2012; 7: e30772.","journal-title":"PLoS One"},{"key":"BFonc2013177_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/1541-7786.MCR-11-0337","volume":"10","author":"LE Young","year":"2012","unstructured":"Young LE, Moore AE, Sokol L, Meisner-Kober N, Dixon DA . The mRNA stability factor HuR inhibits MicroRNA-16 targeting of COX-2. Mol Cancer Res 2012; 10: 167\u2013180.","journal-title":"Mol Cancer Res"},{"key":"BFonc2013177_CR56","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1038\/emboj.2009.156","volume":"28","author":"J Pothof","year":"2009","unstructured":"Pothof J, Verkaik NS, van IJcken W, Wiemer EA, Ta VT, van der Horst GT et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 2009; 28: 2090\u20132099.","journal-title":"EMBO J"},{"key":"BFonc2013177_CR57","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-10-0697","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Wan G, Mlotshwa S, Vance V, Berger FG, Chen H et al. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res 2010; 70: 7176\u20137186.","journal-title":"Cancer Res"},{"key":"BFonc2013177_CR58","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD\/SCID\/gamma(c)(null)mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175\u20133182.","journal-title":"Blood"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:42:41Z","timestamp":1647891761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,20]]},"references-count":58,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,4,24]]}},"alternative-id":["BFonc2013177"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.177","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,20]]},"assertion":[{"value":"7 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}